IIEKKING G DOUG (CIK 1203346) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy USNA (7,469 shares), Sell USNA (5,031 shares), Buy USNA (3,532 shares), Sell USNA (2,567 shares), Buy USNA (2,231 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Buy | 7,469 | $0 |
| 2026-03-03 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 5,031 | $108,267 |
| 2026-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Buy | 3,532 | $0 |
| 2026-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 2,567 | $54,780 |
| 2026-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Buy | 2,231 | $0 |
| 2026-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 1,612 | $34,400 |
| 2026-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Buy | 4,084 | $0 |
| 2026-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 2,746 | $58,600 |
| 2025-05-12 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 4,548 | $134,666 |
| 2025-02-11 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Buy | 2,322 | $0 |
| 2025-02-11 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 1,564 | $47,937 |
| 2025-02-11 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Buy | 4,085 | $0 |
| 2025-02-11 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 2,752 | $84,349 |
| 2025-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Buy | 3,533 | $0 |
| 2025-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 2,027 | $63,263 |
| 2025-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Buy | 2,232 | $0 |
| 2025-02-10 | USANA HEALTH SCIENCES INC (USNA) | CHIEF FINANCIAL OFFICER | Sell | 1,281 | $39,263 |
Source: SEC Form 4 filings · as of 2026-03-03